, Tracking Stock Market Picks
Enter Symbol:
Keryx Biopharmaceuticals, Inc. (KERX) [hlAlert]

down 9.35 %

Keryx Biopharmaceuticals, Inc. (KERX) rated Sell by Citigroup

Posted on: Thursday,  Sep 3, 2015  10:25 AM ET by Citigroup

Citigroup rated Sell Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) on 09/03/2015, when the stock price was $5.62. Since
then, Keryx Biopharmaceuticals, Inc. has gained 10.32% as of 01/12/2016's recent price of $6.20.
If you would have followed this Citigroup's recommendation on KERX, you would have lost 9.35% of your investment in 131 days.

Keryx Biophamaceutical, Inc. uses data discovered through the mapping of the human genome to generate drug candidates that target the regulation of protein kinases. Protein kinases play a key role in the way cells communicate.

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/3/2015 10:25 AM Sell
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy